{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:34:18Z","timestamp":1790890458656,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jinf.2020.02.009","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T02:26:19Z","timestamp":1582338379000},"page":"536-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection"],"prefix":"10.1016","volume":"80","author":[{"given":"Elisa","family":"Petruccioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Chiacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Cuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cimaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Ruffo","family":"Codecasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pinnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.02.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0003","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0004","first-page":"54","article-title":"Global tuberculosis prevention: should we start from the beginning?","author":"Sotgiu","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0005","unstructured":"WHO. Global tuberculosis report 2019:https:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"10.1016\/j.jinf.2020.02.009_bib0006","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2020.02.009_bib0007","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.lpm.2017.01.017","article-title":"The cursed duet today: tuberculosis and HIV-coinfection","volume":"46","author":"Tiberi","year":"2017","journal-title":"Presse Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0008","article-title":"Latent tuberculosis infection screening in persons newly-diagnosed with hiv infection in italy: a multicentre study promoted by the Italian society of infectious and tropical diseases","author":"Goletti","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0009","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jinf.2013.02.004","article-title":"IFNgamma\/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis","volume":"66","author":"Petruccioli","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1469-0691.2006.01391.x","article-title":"Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study","volume":"12","author":"Goletti","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0011","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2334-9-182","article-title":"New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response","volume":"9","author":"Butera","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0012","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jinf.2014.06.009","article-title":"Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients","volume":"69","author":"Chiacchio","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0013","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1183\/13993003.01084-2016","article-title":"Preliminary data on precision of quantiferon-TB plus performance","volume":"48","author":"Cirillo","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinf.2019.04.010","article-title":"Characterization of QuantiFERON-TB-plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases","volume":"79","author":"Chiacchio","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0015","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB plus","volume":"73","author":"Petruccioli","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0016","doi-asserted-by":"crossref","first-page":"15626","DOI":"10.1038\/s41598-018-33825-w","article-title":"Effect of therapy on QuantiFERON-plus response in patients with active and latent tuberculosis infection","volume":"8","author":"Petruccioli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2020.02.009_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2020.02.009_bib0018","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-tb gold plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0019","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1183\/13993003.02033-2015","article-title":"First independent evaluation of QuantiFERON-tb plus performance","volume":"47","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0020","unstructured":"QuantiFERON\u00ae-TB Gold Plus, ELISA package insert, quiagen. http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/PLUS\/2PK-Elisa\/UK.pdf."},{"key":"10.1016\/j.jinf.2020.02.009_bib0021","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/ciu795","article-title":"Combined use of mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis","volume":"60","author":"Rozot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0022","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/eji.201243262","article-title":"Mycobacterium tuberculosis-specific CD8+ t cells are functionally and phenotypically different between latent infection and active disease","volume":"43","author":"Rozot","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0023","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","article-title":"Antigen-specific CD4- and CD8-positive signatures in different phases of mycobacterium tuberculosis infection","volume":"75","author":"Nikolova","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201107-1355OC","article-title":"CD8+ t cells provide an immunologic signature of tuberculosis in young children","volume":"185","author":"Lancioni","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0025","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.4049\/jimmunol.1101122","article-title":"Functional capacity of mycobacterium tuberculosis-specific t cell responses in humans is associated with mycobacterial load","volume":"187","author":"Day","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2018.04.001","article-title":"Impact of antiretroviral and tuberculosis therapies on CD4(+) and CD8(+) HIV\/M. tuberculosis-specific T-cell in co-infected subjects","volume":"198","author":"Chiacchio","year":"2018","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jinf.2020.02.009_bib0027","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","article-title":"Evaluation of IP-10 in quantiferon-plus as biomarker for the diagnosis of latent tuberculosis infection","volume":"111","author":"Petrone","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2020.02.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01089-2018","article-title":"Can we predict tuberculosis cure? What tools are available?","volume":"52","author":"Goletti","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0029","first-page":"56","article-title":"QuantiFERON-TB gold plus is a more sensitive screening tool than QuantiFERON-tb gold in-tube for latent tuberculosis infection among older adults in long-term care facilities","author":"Chien","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12995-017-0159-4","article-title":"Prevalence of latent tuberculosis infection among foreign students in Lubeck, Germany tested with QuantiFERON-tb gold in-tube and QuantiFERON-tb gold plus","volume":"12","author":"Gallegos Morales","year":"2017","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0031","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A multicentre verification study of the QuantiFERON((r))-tb gold plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2020.02.009_bib0032","first-page":"56","article-title":"Comparative evaluation of QuantiFERON-tb gold in-tube and quantiferon-tb gold plus in diagnosis of latent tuberculosis infection in immunocompromised patients","author":"Ryu","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0033","first-page":"56","article-title":"Comparison of the QuantiFERON-tb gold plus and QuantiFERON-tb gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","author":"Theel","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON tb gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.02.009_bib0035","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON((r))-tb gold plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193589","article-title":"Performance of QuantiFERON-tb gold plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting","volume":"13","author":"Konig Walles","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.02.009_bib0037","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test variability of the QuantiFERON-tb gold in-tube assay in clinical practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/eri.12.150","article-title":"IFN-gamma release assay versus tuberculin skin test for monitoring tb infection in healthcare workers","volume":"11","author":"Nienhaus","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2020.02.009_bib0039","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2334-10-220","article-title":"Predictors of persistently positive mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers","volume":"10","author":"Ringshausen","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115322","article-title":"Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the igra in german healthcare workers","volume":"9","author":"Schablon","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.02.009_bib0041","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","article-title":"Challenges with QuantiFERON-tb gold assay for large-scale, routine screening of U.S. healthcare workers","volume":"188","author":"Slater","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0042","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-tb gold-plus in health care workers in a low-incidence setting","volume":"55","author":"Moon","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2020.02.009_bib0043","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1513\/AnnalsATS.201405-188OC","article-title":"Reproducibility of interferon gamma (IFN-gamma) release assays","volume":"11","author":"Tagmouti","year":"2014","journal-title":"Syst Rev Ann Am Thorac Soc"},{"key":"10.1016\/j.jinf.2020.02.009_bib0044","first-page":"50","article-title":"Proof of concept that most borderline QuantiFERONresults are true antigen-specific responses","author":"Uzorka","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0045","first-page":"52","article-title":"Tuberculosis after a borderline QuantiFERONresult during screening before infliximab","author":"Uzorka","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.02.009_bib0046","unstructured":"Strobe Group University of Bern. Strobe Statement. https:\/\/wwwstrobe-statement org\/index php?id=strobe-single-news-view&tx_news_pi1%5Bnews%5D=146&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=1313eacdf5efcb43416881ec91b8a1e6 2014."},{"key":"10.1016\/j.jinf.2020.02.009_bib0047","article-title":"Observational studies: getting clear about transparency","volume":"11","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0048","unstructured":"World medical association. WMA declaration of Helsinki \u2013 ethical principles for medical research involving human subjects 2013. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"10.1016\/j.jinf.2020.02.009_bib0049","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jinf.2020.02.009_bib0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of mycobacterium tuberculosis infection","volume":"196","author":"Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.02.009_bib0051","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jinf.2020.02.009_bib0052","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2020.02.009_bib0053","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.02.009_bib0054","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2249.2007.03462.x","article-title":"Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study","volume":"150","author":"Vincenti","year":"2007","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320300931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320300931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:19Z","timestamp":1759008499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320300931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0163445320300931"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.02.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}